agilon health, inc. 8-K

What Happened
agilon health, inc. announced its financial results for the three months ended March 31, 2026 in a press release dated May 6, 2026. The company furnished the press release as Exhibit 99.1 to its Form 8-K (Item 2.02) and incorporated that release by reference into the filing.

Key Details

• Filing date: May 6, 2026; quarter covered: three months ended March 31, 2026.
• Disclosure type: Item 2.02 (Results of Operations and Financial Condition); press release furnished as Exhibit 99.1.
• Interactive data: Exhibit 104 (Cover Page Interactive Data File embedded in the Inline XBRL document).
• Form 8-K signed by Jeffrey Schwaneke, Chief Financial Officer, on behalf of agilon health.

Why It Matters
This 8-K signals that agilon has released its quarterly earnings and other financial metrics for Q1 2026. Retail investors should review the attached press release (Exhibit 99.1) and the company’s accompanying financial tables/XBRL for key figures—revenue, profit/loss, margins, cash flow and any commentary on outlook or guidance—that could affect the stock’s near-term performance and valuation. The filing itself provides official, SEC-filed disclosure of those results.